Login
Toggle navigation
Videos
Categories
Trending
Immunicum | CEO interview, Erik Manting, CEO, Immunicum
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Immunicum | CEO interview, Erik Manting, CEO, Immunicum
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Empowering Financial Literacy: Insights from Mutual Fund Industry Leaders | DP Singh , CBO , SBI Mutual Fund.
00:10:00
Global Architecture and Construction Needs Rethinking|Andrew Anagnost,President and CEO,Autodesk
00:10:00
Navarre Minerals: Advancing Gold Discoveries in Victoria's Golden Triangle
00:10:00
Invests in today’s most promising energy innovators and works with the world’s leading energy companies|Jason Blumberg,Co-Founder and Managing Director,Energy Foundry
00:10:00
CAE Inc. (TSX:CAE) is captured in a filming session dated September 20, 2016, accessible through
00:00:00
Arlene Sharpe Kolokotrones University Professor, HMS
00:10:00
Silver Tiger Mines Positioned for Success Amidst Growing Silver Market
00:10:00
Navigating the Challenges: Financial Planning for the Sandwich Generation
00:10:00
Exploring Company Achievements: Insights on Water Tank Success and Future Prospects|LALIT DAMODAR MEHTA,Managing Director,Samrat Pharmachem Ltd.
00:10:00
Journey of Passion: From Market Skeptic to Financial Leader | Roberto Sallouti, CEO , BTG Pactual Group.
00:10:00
David Hunt on Strategic Leadership, Global Markets, and the Future of Asset Management | David Hunt, CEO , PGIM.
00:10:00
Venator Founders Fund: A Long-Short Equity Investment Opportunity for High-Risk Investors